A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 01 Apr 2018
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 18 Dec 2017 Planned number of patients changed from 465 to 358.
- 18 Dec 2017 Planned End Date changed from 18 May 2020 to 15 Nov 2019.
- 18 Dec 2017 Planned primary completion date changed from 18 May 2020 to 15 Nov 2019.